Clinical trials
Completed Phase 4 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
803 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 11 |
| 2002 | 27 |
| 2003 | 35 |
| 2004 | 30 |
| 2005 | 33 |
| 2006 | 28 |
| 2007 | 33 |
| 2008 | 45 |
| 2009 | 55 |
| 2010 | 45 |
| 2011 | 38 |
| 2012 | 38 |
| 2013 | 44 |
| 2014 | 53 |
| 2015 | 57 |
| 2016 | 49 |
| 2017 | 29 |
| 2018 | 31 |
| 2019 | 27 |
| 2020 | 18 |
| 2021 | 20 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 803 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 71 |
| Sanofi | 67 |
| Eli Lilly and Company | 29 |
| AstraZeneca | 25 |
| GlaxoSmithKline | 19 |
| Novartis Pharmaceuticals | 19 |
| Emory University | 13 |
| Takeda | 12 |
| The University of Texas Health Science Center at San Antonio | 12 |
| Boehringer Ingelheim | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 803 |
| Diabetes Mellitus | 192 |
| Insulin Resistance | 56 |
| Hypertension | 42 |
| Coronary Artery Disease | 31 |
| Obesity | 31 |
| Hyperglycemia | 20 |
| Dyslipidemias | 19 |
| Cardiovascular Diseases | 16 |
| Non-alcoholic Fatty Liver Disease | 14 |
Trials
Showing 1 to 25 of 803. Each trial links to its page on Pharma Observatory.
703 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.